Purple Biotech Ltd. (PPBT)
1.64
-0.01
(-0.61%)
USD |
NASDAQ |
Aug 26, 12:18
Purple Biotech Shareholders Equity (Quarterly) : 12.27M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.27M |
| March 31, 2026 | 9.722M |
| December 31, 2025 | 9.714M |
| September 30, 2025 | 32.77M |
| June 30, 2025 | 32.01M |
| March 31, 2025 | 32.65M |
| December 31, 2024 | 32.86M |
| September 30, 2024 | 29.41M |
| June 30, 2024 | 29.32M |
| March 31, 2024 | 31.02M |
| December 31, 2023 | 34.21M |
| September 30, 2023 | 38.60M |
| June 30, 2023 | 42.60M |
| March 31, 2023 | 46.88M |
| December 31, 2022 | 46.91M |
| September 30, 2022 | 51.89M |
| June 30, 2022 | 55.41M |
| March 31, 2022 | 58.06M |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 9.429M |
| September 30, 2015 | 0.131M |
| June 30, 2015 | 1.132M |
| March 31, 2015 | 2.278M |
| December 31, 2014 | 0.8577M |
| September 30, 2014 | 1.689M |
| June 30, 2014 | 0.787M |
| March 31, 2014 | 2.09M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | 7.753B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 35.64M |
| Sol-Gel Technologies Ltd. | 48.10M |
| PolyPid Ltd. | 5.388M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.17M |
| Total Liabilities (Quarterly) | 1.953M |
| Debt to Equity Ratio | 0.0109 |
| Current Ratio | 3.696 |
| Net Debt Paydown Yield | 0.02% |